Breast cancer prediction using genome wide single nucleotide polymorphism data

Abstract

BackgroundThis paper introduces and applies a genome wide predictive study to learn a model that predicts whether a new subject will develop breast cancer or not, based on her SNP profile.ResultsWe first genotyped 696 female subjects (348 breast cancer cases and 348 apparently healthy controls), predominantly of Caucasian origin from Alberta, Canada using Affymetrix Human SNP 6.0 arrays. Then, we applied EIGENSTRAT population stratification correction method to remove 73 subjects not belonging to the Caucasian population. Then, we filtered any SNP that had any missing calls, whose genotype frequency was deviated from Hardy-Weinberg equilibrium, or whose minor allele frequency was less than 5%. Finally, we applied a combination of MeanDiff feature selection method and KNN learning method to this filtered dataset to produce a breast cancer prediction model. LOOCV accuracy of this classifier is 59.55%. Random permutation tests show that this result is significantly better than the baseline accuracy of 51.52%. Sensitivity analysis shows that the classifier is fairly robust to the number of MeanDiff-selected SNPs. External validation on the CGEMS breast cancer dataset, the only other publicly available breast cancer dataset, shows that this combination of MeanDiff and KNN leads to a LOOCV accuracy of 60.25%, which is significantly better than its baseline of 50.06%. We then considered a dozen different combinations of feature selection and learning method, but found that none of these combinations produces a better predictive model than our model. We also considered various biological feature selection methods like selecting SNPs reported in recent genome wide association studies to be associated with breast cancer, selecting SNPs in genes associated with KEGG cancer pathways, or selecting SNPs associated with breast cancer in the F-SNP database to produce predictive models, but again found that none of these models achieved accuracy better than baseline.ConclusionsWe anticipate producing more accurate breast cancer prediction models by recruiting more study subjects, providing more accurate labelling of phenotypes (to accommodate the heterogeneity of breast cancer), measuring other genomic alterations such as point mutations and copy number variations, and incorporating non-genetic information about subjects such as environmental and lifestyle factors.

Bayesian and Machine Learning Models for Genomic Prediction of Anterior Cruciate Ligament Rupture in the Canine Model

“…SNPs were selected for inclusion in the training set by one of two filter methods: 1) ranked P -values from a linear mixed model GWAS using the R package ‘gaston’ ( Perdry and Dandine-Roulland 2015 ), where smaller P -values were considered more likely to be associated with ACL rupture or 2) ranked SNPs based on the mean difference in allele frequency between cases and controls. SNPs with the largest mean difference were considered to be the most likely associated with ACL rupture ( Hajiloo et al 2013 ). The number of genetic variants believed to affect ACL rupture in dogs is unknown, though there are likely hundreds to thousands of non-null effect SNPs ( Baker et al 2017 ; Baker et al 2018 ).…”

Machine learning approach to single nucleotide polymorphism-based asthma prediction

“…SVM along with Naive Bayes and decision trees have also been used to identify breast cancer cases using SNPs selected via information gain [14]. Furthermore, mean difference calculation and k-nearest neighbor (kNN) have also been employed to quantify SNP relevance and to perform classification task on the breast cancer dataset [15], respectively.…”

Physiological variables and molecular study of KLK2 and KLK3 among patient with benign prostatic hyperplasia

“…23 The genetic targets such as SNPs may evaluate as genetic signs promising to better understand genetic bases of various complex diseases, including benign tumor or cancer. 24 Single nucleotide polymorphism represents approximately 90% of the variations. This means that the SNPs are most common variations in human genome.…”